SS Innovations Appoints Sarah Romano as CFO to Drive Financial Strategy and FDA Approval Pursuit

SS Innovations International appoints seasoned medtech finance leader Sarah Romano as CFO to lead financial operations amid its global expansion and pursuit of U.S. FDA approval for the SSi Mantra surgical robotic system.

Miami Metrowire Staff
Healthcare
SS Innovations Appoints Sarah Romano as CFO to Drive Financial Strategy and FDA Approval Pursuit

SS Innovations International, Inc. (NASDAQ: SSII), a developer of surgical robotic technologies, announced the appointment of Sarah M. Romano as chief financial officer, effective August 3, 2026. Romano, based in the United States, brings over two decades of finance leadership experience in the medical technology and life sciences sectors. Her appointment is expected to bolster the company's financial operations as it advances its global expansion strategy, including the pursuit of U.S. FDA approval for its SSi Mantra surgical robotic system.

Most recently, Romano served as CFO of Vicarious Surgical, where she led financial and operational initiatives to reduce cash burn, strengthen the balance sheet, and support strategic objectives. She previously held CFO roles at Entero Therapeutics and Kiora Pharmaceuticals, raising more than $100 million through public and private financings while overseeing strategic transactions, SEC reporting, and investor relations. Her extensive background in capital markets and corporate finance is expected to be instrumental as SS Innovations seeks to scale its operations and bring its robotic surgery platform to new markets.

SS Innovations develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible globally. The company's product range includes its proprietary SSi Mantra surgical robotic system and its comprehensive suite of SSi Mudra surgical instruments, which support various procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions.

The appointment of Romano comes at a critical time for SS Innovations as it prepares for FDA submission and potential commercialization in the United States. Her experience in navigating regulatory and financial complexities in the medtech space is likely to provide strategic direction. The company's focus on affordability and accessibility could address a significant need in the global surgical robotics market, which has been dominated by high-cost systems.

For more information about SS Innovations and its latest developments, visit the company's newsroom at https://ibn.fm/SSII. The full press release is available at https://ibn.fm/pAqlP.

Blockchain Registration

QR Code for Blockchain Registration